SCHEMBL7090318

SCHEMBL7090318

Brc1ccc(-c2n[nH]c3c2sc2ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 2/20 0.41
FLT3 P36888 2/20 0.41
DCLK1 O15075 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
CHEK2 O96017 1/20 0.41
FER P16591 1/20 0.41
CDK2 P24941 1/20 0.41
MARK3 P27448 1/20 0.41
FLT4 P35916 1/20 0.41
MAPK9 P45984 1/20 0.41
CSNK1D P48730 1/20 0.41
CLK2 P49760 1/20 0.41
CSNK2A1 P68400 1/20 0.41
CSNK1G2 P78368 1/20 0.41
MAP4K2 Q12851 1/20 0.41
STK3 Q13188 1/20 0.41
CAMK2B Q13554 1/20 0.41
CAMK2G Q13555 1/20 0.41
DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000848 0.88 ALDH1A1 (0.49) CSF1RFLT3DCLK1PRKD3MAP4K4
SCHEMBL7095837 0.85 MEN1 (0.51) CSF1RFLT3MEN1KMT2AMAPT
SCHEMBL7096389 0.85 MAPT (0.41) CSF1RFLT3MAP4K4AURKBCLK4
SCHEMBL7094698 0.85 PDPK1 (0.43) MEN1KMT2AMAPTRAB9AALDH1A1
SCHEMBL7698784 0.82 ALDH1A1 (0.46) CDK2MAPK9DYRK1AMEN1KMT2A
SCHEMBL6994774 0.82 MEN1 (0.38) CSF1RFLT3MEN1KMT2AMAPT
SCHEMBL20035103 0.80 HTR2B (0.42) CDK2MAPK9AURKBMEN1KMT2A
SCHEMBL7091161 0.80 MAP2K4 (0.45) MKNK2ALDH1A1KDM4EROCK1MAPK1
SCHEMBL7096045 0.75 LRRK2 (0.43) FLT3MAP4K4CSNK1DCLK2DYRK1A
SCHEMBL7092191 0.74 CXCR4 (0.51) CSF1RFLT3PRKD3FERCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed